نتایج جستجو برای: transarterial ethanol ablation
تعداد نتایج: 158521 فیلتر نتایج به سال:
Peripheral Arteriovenous Malformations with a Dominant Outflow Vein: Results of Ethanol Embolization
OBJECTIVE To assess retrospectively the treatment results of ethanol embolization of peripheral arteriovenous malformations (AVMs) with a dominant outflow vein (DOV). MATERIALS AND METHODS Nineteen patients who had peripheral AVMs with a DOV were enrolled in this study (mean age, 29.7 years; range, 15-42 years). Fifty-one ethanol embolizations (mean, 2.7; range, 1-8) were performed by direct ...
BACKGROUND AND OBJECTIVES To provide an overview on the loco-regional therapy performed by transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC), either as sole, either as neoadjuvant to surgery or bridge therapy to orthotopic liver transplantation (OLT). EVIDENCE AND INFORMATION SOURCES The current review is based on an analysis of the current literature and ...
BACKGROUND The size and number of tumors are important prognostic indicators for hepatocellular carcinoma (HCC). However, it is difficult to assess the prognosis for patients with a variable number and size of tumors. By combining these two factors, we investigated the role and prognostic accuracy of total tumor volume (TTV) for HCC. METHODS A total of 786 patients undergoing locoregional the...
BACKGROUND We evaluated the clinical efficacy of transarterial infusion chemotherapy using a cisplatin-lipiodol emulsion for unresectable hepatocellular carcinoma (HCC). PATIENTS AND METHODS Fifty-seven patients with advanced HCC, with no indications for surgical resection or local ablative therapy, such as percutaneous ethanol injection and radiofrequency ablation, were enrolled in this retr...
OBJECTIVE To evaluate the survival benefit of multimodal therapy for the treatment of HCC. BACKGROUND Orthotopic liver transplantation (OLT) is considered the treatment of choice for selected patients with hepatocellular carcinoma (HCC). However, donor organ shortages and patients whose HCCs exceed OLT criteria require consideration of alternate therapeutic options such as hepatic resection, ...
Hepatocellular carcinoma (HCC) continues to be one of the worst cancer conditions worldwide, being the sixth most common cancer and associated with a 5-year overall survival rate of only 5% (1). Surgery, either in terms of local resection or liver transplant, is still the treatment of choice, with 5-year survival rates of 30–70% (2). However, o 20% of patients qualify for this treatment because...
The treatment options for hepatocellular carcinoma (HCC) are liver resection, liver transplantation, or local ablation (e.g., percutaneous ethanol injection, cryosurgery, radio-frequency ablation, and chemoembolization). Most patients are not eligible for curative resection because of the location of the tumor or the severity of liver disease. For many of these patients, liver transplantation r...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید